Screening compound: C27H33N5O5S2 (K403-1143)

Screening compound: C<sub>27</sub>H<sub>33</sub>N<sub>5</sub>O<sub>5</sub>S<sub>2</sub> (K403-1143)
Screening compound: C<sub>27</sub>H<sub>33</sub>N<sub>5</sub>O<sub>5</sub>S<sub>2</sub> (K403-1143) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C27H33N5O5S2 (K403-1143)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K403-1143

Molecular Formula

C27H33N5O5S2 (C27 H33 N5 O5 S2)

Compound Name

ethyl 2-{2-[(4-cyclohexyl-5-{[(furan-2-yl)formamido]methyl}-4H-1,2,4-triazol-3-yl)sulfanyl]propanamido}-4H,5H,6H-cyclopenta[b]thiophene-3-carboxylate

IUPAC name

ethyl 2-{2-[(4-cyclohexyl-5-{[(furan-2-yl)formamido]methyl}-4H-124-triazol-3-yl)sulfanyl]propanamido}-4H5H6H-cyclopenta[b]thiophene-3-carboxylate

SMILES

CCOC(c1c(NC(C(C)Sc2nnc(CNC(c3ccco3)=O)n2C2CCCCC2)=O)sc2c1CCC2)=O

InChI

InChI=1S/C27H33N5O5S2/c1-3-36-26(35)22-18-11-7-13-20(18)39-25(22)29-23(33)16(2)38-27-31-30-21(32(27)17-9-5-4-6-10-17)15-28-24(34)19-12-8-14-37-19/h8,12,14,16-17H,3-7,9-11,13,15H2,1-2H3,(H,28,34)(H,29,33)/t16-/m0/s1

InChI Key

ITAIPQXAZLTWKV-INIZCTEOSA-N

MDL Number (MFCD)

MFCD04411486

C27H33N5O5S2 (K403-1143) in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Eccentric PPI Library (11937 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • Epigenetic
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds
Targets:
  • Others
  • GPCR

References: we are preparing a list of scientific research reports with C27H33N5O5S2 (K403-1143) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C27H33N5O5S2 (K403-1143)?
Check Price and Availability of C27H33N5O5S2 (K403-1143), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C27H33N5O5S2 (K403-1143) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C27H33N5O5S2 (K403-1143)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C27H33N5O5S2 (K403-1143)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C27H33N5O5S2 (K403-1143) available by request